StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Core Income Before Taxes by Quarter

Core Income Before Taxes ($M)

QuarterlyAnnual

Novartis Core Income Before Taxes: $5,551M in Q3 2026, up 7.4% from a year earlier.

Latest, Q3 2026
5,551
Period ended Sep 30, 2026
Change on a year earlier
+7.4%
5,168 in Q3 2025
History
29 quarters
Since Q4 2017
Sources
19
Documents cited below

Where the Q3 2026 figure comes from

“|| Income before taxes | 1 317 | 886 | 2 267 | 106 | 975 | 5 551 | 5 168”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCore Income Before Taxes ($M)Year on yearSource
Q3 2026Sep 30, 20265,551+7.4%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20265,495-2.2%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20264,555-14.8%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20254,641-0.5%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20255,168+4.8%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20255,620+17.9%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 20255,348+21.3%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20244,664–Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20244,933–Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20244,765+4.7%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20244,409+2.1%Novartis Form 6-K (0001370368-25-000010) ↗
Q2 2023Jun 30, 20234,553+10.3%Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 20234,318+10.4%Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 20223,862+4.9%Novartis Form 6-K (0001370368-23-000008) ↗
Q3 2022Sep 30, 20224,057-11.0%Novartis Form 6-K (0001370368-22-000077) ↗
Q2 2022Jun 30, 20224,129-6.7%Novartis Form 6-K (0001370368-23-000059) ↗

Cite this data

StockData. (2026). Novartis Core Income Before Taxes ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-pretax-income

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.